| AREPA | acetazolamide-responsive familial paroxysmal ataxia |
|---|---|
| Tabs | tablets |
| ACTZ | Acetazolamide |
|---|---|
| ACZ | Acetazolamide |
| AZ | Acetazolamide |
| AZM | Acetazolamide |
| acetazolamide | <chemical> A carbonic anhydrase inhibitor that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. Pharmacological action: anticonvulsants, carbonic anhydrase inhibitors, diuretics. Chemical name: Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)- (12 Dec 1998) |
|---|---|
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|